Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
450.8 USD | +0.73% | +2.31% | +10.79% |
May. 22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
May. 21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.67% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - | |
5.20% | 2 M€ | -.--% | ||
4.81% | 7 M€ | -.--% | - | |
4.05% | 110 M€ | +9.97% | - | |
3.53% | 1 M€ | 0.00% | - | |
2.32% | 2 M€ | 0.00% | ||
2.28% | 8 M€ | 0.00% | ||
1.99% | 12 M€ | +15.09% | - | |
1.93% | 0 M€ | 0.00% | - | |
1.71% | 2 M€ | -25.75% | ||
1.63% | 17 M€ | +7.28% | - | |
1.61% | 253 M€ | +6.93% | ||
1.58% | 9 M€ | -4.31% | - | |
1.10% | 204 M€ | +10.54% | ||
1.06% | 1,100 M€ | +3.85% | ||
0.87% | 9 M€ | -.--% | - | |
0.82% | 13 M€ | -.--% | - | |
0.82% | 3 M€ | +15.16% | - | |
0.82% | 4 M€ | -.--% | - | |
0.81% | 26 M€ | +16.85% | - | |
0.73% | 15 M€ | 0.00% | - | |
0.69% | 5 M€ | -72.95% | - | |
0.68% | 3 M€ | 0.00% | - | |
0.51% | 727 M€ | +9.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B | |
-34.35% | 7.77B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated